SHSAX Holdings Information

SHSAX is a mutual fund with a total of 166 individual holdings. The top holdings are Eli Lilly and Company stock at 10.79%, Johnson & Johnson at 9.51%, UnitedHealth Group at 6.00%, Merck & Co. at 4.34%, and AbbVie at 4.18%.

Total Holdings

166

Top 10 Percentage

50.70%

Asset Class

Equity

Fund Category

Health

Assets

5.91B

Forward PE Ratio

18.94

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	10.79%	674,971
2	JNJ	Johnson & Johnson	9.51%	2,417,953
3	UNH	UnitedHealth Group Incorporated	6.00%	947,412
4	MRK	Merck & Co., Inc.	4.34%	2,322,061
5	ABBV	AbbVie Inc.	4.18%	1,157,700
6	GILD	Gilead Sciences, Inc.	3.89%	1,736,422
7	AMGN	Amgen Inc.	3.48%	588,158
8	TMO	Thermo Fisher Scientific Inc.	2.97%	362,337
9	ISRG	Intuitive Surgical, Inc.	2.84%	362,870
10	PFE	Pfizer Inc.	2.69%	5,899,018
11	VRTX	Vertex Pharmaceuticals Incorporated	2.65%	361,907
12	EW	Edwards Lifesciences Corporation	2.44%	1,710,975
13	ABT	Abbott Laboratories	2.12%	1,361,894
14	TEVA	Teva Pharmaceutical Industries Limited	2.08%	3,475,093
15	DHR	Danaher Corporation	1.97%	645,138
16	BSX	Boston Scientific Corporation	1.92%	1,945,032
17	ARGX	argenx SE	1.62%	121,340
18	LON: AZN	AstraZeneca PLC	1.25%	384,355
19	SYK	Stryker Corporation	1.20%	221,948
20	BIIB	Biogen Inc.	1.18%	364,188
21	REGN	Regeneron Pharmaceuticals, Inc.	1.06%	87,659
22	BMY	Bristol-Myers Squibb Company	0.95%	917,026
23	HCA	HCA Healthcare, Inc.	0.93%	125,705
24	INSM	Insmed Incorporated	0.91%	392,149
25	RVMD	Revolution Medicines, Inc.	0.89%	361,340

Showing 25 of 166 holdings

Subscribe to see the full list

Activate Now

As of Apr 30, 2026